Stage FocusPre-Seed, Seed, Series A, Series B+
GeographyUK, Europe
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Syncona is not a typical VC — it's a FTSE250-listed company that founds, builds, and funds transformational healthcare companies, with a biotech portfolio valued at £1.2B. The public listing creates an unusual dynamic: shares trade at roughly a 45% discount to net asset value (market cap ~£659M), which means public market investors are effectively getting the portfolio at half price. In 2024/25, S...
Notable Investments
A
AutolusB
Beacon TherapeuticsQ
Quell TherapeuticsR
Resolution TherapeuticsSimilar Funds
LifeArc Ventures
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Abingworth
London, United Kingdom
DeepTech NativeBiotechMedTechSeedSeries A
Amino Collective
Berlin, Germany
DeepTech NativeBiotechSynthetic BiologyMedTechPre-SeedSeed
Brandon Capital
Melbourne, Australia
DeepTech NativeBiotechMedTechSeedSeries A
Cambridge Innovation Capital
Cambridge, United Kingdom
Pure DeepTechBiotechQuantum ComputingSemiconductorsSeedSeries A
HealthCap
Stockholm, Sweden
DeepTech NativeBiotechMedTechSeedSeries A